Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($1.06), $0.19 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $63 million versus the consensus estimate of $51.58 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.